ArticleHepatobiliary surgery and nutrition2022

Glucose-lowering agents and reduced risk of incident non-alcoholic fatty liver disease: new insights.

Alessandro Mantovani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.